LineaGen Raises $5.8M For Molecular Diagnostics Firm
Salt Lake City, Utah-based LineaGen said today that it has raised $5.8M in funding from vSpring Capital and Sanderling Biomedical Ventures, along with Mesa Verde Venture Partners. The firm said it is looking to discover and commercialize significant molecular diagnostic innovations. Lineagen said that its initial focus in on diagnostic tools for the advancement of personalized healthcare.
posted on Wednesday, December 19, 2007 (Link to more information)
Related companies:
Lineagen
Related stories:
> Lineagen Lands $19.8M For Molecular Diagnostics Effort
> Lineagen Lands $3.5M
> HTG Molecular Diagnostics Files For IPO
> Lineagen Raises $5M
> BioFire Diagnostics Lands $25M For Molecular Diagnostics Tools
Techrockies.com Home